Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Cuscuta reflexa extracts and an isolate promoted hair growth and could be natural treatments for hair loss.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

SHBG may be a useful early indicator and treatment target for PCOS.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

Oestrogens are key for bone growth during puberty in both boys and girls.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.